Colleen Gabel is a Dermatology physician. OpenAlex indexes 45 publications with 241 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1601 Congress St
Portland, ME 041022102
Telephone
207-661-0100Provider last certified this registry record 7 May 2026.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
21.7%Corticosteroid12.1%Triamcinolone Acetonide100%Part D≥28 patientsInterleukin-4 Receptor alpha Antagonist7.2%Dupixent Pen100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
20.6%Interleukin-17A Antagonist7.2%Taltz Autoinjector65%Cosentyx Sensoready (2 Pens)35%Part D<11 patientsCalcineurin inhibitor4%Tacrolimus100%Part D≥12 patients+ 3 more classes in this area
Anti-infectives
19.3%Azole Antifungal11%Ketoconazole100%Part D≥28 patientsTetracycline-class Drug5.5%Doxycycline Monohydrate100%Part D≥16 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 62101 A 6-year retrospective analysis of dermatology referrals for cancer patients at a Tertiary Academic Health System
Journal of the American Academy of Dermatology
2025 - Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study
Journal of the American Academy of Dermatology
2024 - A Case of Rapidly Progressive Unilateral Non-Nephrogenic Hemorrhagic Bullous Calciphylaxis Responding to Systemic Sodium Thiosulfate Therapy
WOUNDS A Compendium of Clinical Research and Practice
2024 - Prevalence and risk factors for development of recurrent calciphylaxis
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”